BDBM281046 US10022352, Compound 307
SMILES: CC(C)(C)c1cc2cc(NC(=O)C3(CC3)c3ccc4CCCc4c3)ccc2n1C[C@@H](O)CO
InChI Key: InChIKey=KVZMYJRGSRFFDD-HSZRJFAPSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM281046![]() (US10022352, Compound 307) | PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 981 | n/a | n/a | n/a | n/a |
Vertex Pharmaceuticals Incorporated US Patent | Assay Description Single-Channel Recordings activity of wt-CFTR and temperature-corrected ΔF508-CFTR expressed in NIH3T3 cells was observed using excised inside-o... | US Patent US10022352 (2018) BindingDB Entry DOI: 10.7270/Q2T43W44 | |||||||||||
More data for this Ligand-Target Pair |